Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

UnitedHealth Group (NY:UNH)

308.55 +0.99 (+0.32%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about UnitedHealth Group

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
94 95 Next >
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape
An aging U.S. population is increasing demand for home health care. The Optum-Amedisys merger, with divestitures to VitalCaring, aims to balance growth and competition. 
Via Benzinga
Why Are These 3 Vanguard ETFs Underperforming the S&P 500 Since Election Day?
Stocks in these "safe" sectors are selling off as investors gravitate toward growth. 
Via The Motley Fool
Topics ETFs Stocks
Justice Department Moves To Block UnitedHealth's Amedisys Takeover: What's Going On?
UnitedHealth Group Inc (NYSE:UNH) shares are trading lower Tuesday. The U.S. Justice Department is moving to block the company's multi-billion acquisition of Amedisys Inc (NASDAQ:AMED). 
Via Benzinga
Behind the Scenes of UnitedHealth Group's Latest Options Trends
Via Benzinga
Unpacking the Latest Options Trading Trends in UnitedHealth Group
Via Benzinga
A Closer Look at UnitedHealth Group's Options Market Dynamics
Via Benzinga
In-Depth Analysis: UnitedHealth Group Versus Competitors In Health Care Providers &amp; Services Industry
Via Benzinga
Smart Money Is Betting Big In UNH Options
Via Benzinga
3 Under-the-Radar Healthcare Companies
While established healthcare firms are among the most stable stocks in the sector, up-and-coming companies can offer the potential for greater gains. 
Via MarketBeat
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Investors Like Certainty. Trump's Win Gave Them Some.
We're also talking about Super Micro, Nvidia, and weight loss. 
Via The Motley Fool
Topics Government
16 Analysts Assess UnitedHealth Group: What You Need To Know
Via Benzinga
2 Healthcare Dividend Stocks That Are Screaming Buys in November
One stock yields 6% today. Another has grown its dividend by 460% over the past decade. Both are blue chip bargains to buy right now. 
Via The Motley Fool
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
From UnitedHealth Group
Via Business Wire
This Could Be the Next Major Artificial Intelligence (AI) Stock to Undergo a Stock Split
A combination of political and market pressure will probably drive this stock split. 
Via The Motley Fool
Topics Artificial Intelligence
Nvidia Joining Dow Jones Industrial Average: Where Tech Giant Ranks In The Index, Why Sherwin-Williams Addition Could Be More Important
Nvidia is joining the Dow Jones Industrial Average. A look at where one of the largest companies in the world will rank in the key market index. 
Via Benzinga
Topics Stocks
3 Dividend Stocks to Double Up on Right Now
These top-notch dividend growth stocks are rare deals in a market that keeps marching higher. 
Via The Motley Fool
Election Effect: How Presidential Votes Shape Stock Markets Long And Short Term
Politics and election results may have a short-term impact, but in the long run it’s all about the fundamentals of the business you invest in. 
Via Talk Markets
Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 20 Years
Via Benzinga
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
The stocks on this list are the top three buy-and-hold stocks in healthcare, producing significant value for shareholders while leading their respective fields. 
Via MarketBeat
Cigna Considers Humana Acquisition – What It Means for the Stocks
Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky. 
Via MarketBeat
Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks.
These seven companies are transforming steady profits into rising passive income streams for investors. 
Via The Motley Fool
Change Healthcare Cyberattack Toll Could Reach Almost $3 Billion This Year
Via Investor Brand Network
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
These three Vanguard ETFs are worth considering for the long term. 
Via The Motley Fool
Topics ETFs
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
Cigna and Humana are in early-stage merger discussions after a year-long pause. Amid financial pressure, Humana's Medicare Advantage star ratings have plummeted, impacting future revenue. 
Via Benzinga
Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled. 
Via Investor's Business Daily
Oversold But Ready to Rally: 5 Stocks to Watch Now
These stocks are or were oversold based on the RSI index, but future catalysts suggest that these stocks may be or are already starting, a bullish reversal 
Via MarketBeat
Elevance, CVS, UnitedHealth Struggle With Rising Medical Costs After COVID-19 Medicaid Policy Ends
Insurers have reported higher medical costs due to the end of pandemic-era policies. States redetermining Medicaid eligibility created a disparity for insurers. 
Via Benzinga
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review
The Dow Jones and S&P 500 hit highs as they extended weekly win streaks. 
Via Investor's Business Daily
Topics Stocks
Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO
CVS Health replaces CEO Karen Lynch with David Joyner as the company struggles with lower earnings projections and rising medical costs. Q3 2024 results, including a $1.1 billion charge, are expected... 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
94 95 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.